| Name | Title | Contact Details |
|---|---|---|
Edward Ryan |
Sr. Dir, IT, Office of CIO | Profile |
Annlea Rumfola |
EVP, Chief Information Officer | Profile |
Heather Knight |
Chief Operating Officer | Profile |
Chris Toth |
Chief Executive Officer | Profile |
Carl Jenkins |
Associate General Counsel, Legal-Regulatory | Profile |
Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.
AADCO Medical Inc is a Randolph, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oliver Medical Packaging is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
High Technology is a Walpole, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Acutus Medical is committed to pioneering a breakthrough technology to optimize the treatment strategies for complex cardiac arrhythmias by developing innovative, safe, efficacious, and cost-effective solutions for individuals suffering from these complex cardiac arrhythmias. Our mission is to develop and market a platform technology of safe, cost-effective and clinically advanced tools for the minimally invasive diagnosis (mapping) of complex arrhythmias (Atrial Fibrillation and Ventricular Tachycardia) that enable Physicians to optimize treatments and expand the ablation/therapeutic markets. In the pursuit of our mission, we will conduct all of our activities with the highest integrity and strive to become the world’s most valued company within the markets we serve to patients, customers, colleagues, investors, business partners, employees, and the communities in which we work and live.